Immunogenicity endpoints were rates of seroresponse to pertussis toxoid , filamentous hemagglutinin , pertactin and fimbriae types @ and @ ; rates of seroprotection against ( Hib ) polyribosylribitol phosphate capsular polysaccharide , hepatitis B surface antigen , diphtheria toxoid , tetanus toxoid and poliovirus types @ , @ and @ ; and geometric mean titers to all vaccine antigens .